For healthcare professionals only

News Roundup [abridged Versions Appear In The Paper Journal]

Drug company accused of breaking advertising regulations

BMJ 2003; 326 doi: (Published 22 May 2003) Cite this as: BMJ 2003;326:1106
  1. Fabian Waechter
  1. BMJ

    The Drug and Therapeutics Bulletin has accused the drug company Novartis of breaching advertising regulations in its advertisement for pimecrolimus, a new cream for treating dermatitis (2003;41(5):33-6).

    A recent review by the bulletin resulted in three criticisms. The main concern was that while the licence limits the use to patients aged 2 years and older, the recent advertisement, published in many medical journals, shows a baby who looks younger than 2 years, implying that the cream could be used on babies below that age. The bulletin is consequently demanding that the drug's licence be withdrawn.

    But a spokesman …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription